AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Striking back at cancer.(Knight Ridder Newspapers)

Knight Ridder/Tribune News Service

| April 01, 2002 | Jacobs, Paul | COPYRIGHT 2002 Knight-Ridder/Tribune News Service. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

SAN JOSE, Calif. _ It's been a year since Dan Case underwent surgery for brain cancer _ a horrible, transforming year of treatments and occasional setbacks for one of Silicon Valley's most influential investment bankers.

It's been a gratifying year as well, he says, one in which he and his family launched a foundation to seek a cure for a disease that strikes 17,000 Americans each year, most of them children or, like the 44-year-old Case, adults in their prime.

It's been a year in which Case has had to face the grim statistics of his own particular form of cancer but has been buoyed by support for his efforts to do something about it.

``If there's one lesson I got from this, it's much more than `We have to fix brain cancer,' '' Case said. ``It's that people are amazing if you just give them a chance to be kind.''

In the first extended interview he's given since he announced he had the disease last April, Case was philosophical about his plight. While far from giving up hope, he is well aware of the odds against his beating the disease, but enthusiastic about his efforts to make a difference in the outcome, if not for himself, then for others. Although his energy flags now, he still shows the intelligence, humor and drive that brought him to the top of his profession and made him a wealthy man.

He retains the title of chairman of JPMorgan H&Q, the former Hambrecht & Quist, now folded into its much larger parent corporation. But since his surgery he's been working part time.

He's devoting much of his time to family _ the youngest of his ...

Related articles from newspapers, magazines, journals, and more
Plastic & profits: automakers don't have to default to the aftermarket for...
Magazine article from: Automotive Design & Production Sawyer, Christopher A. November 1, 2007 700+ words
Mass personalization is often mentioned, but rarely implemented. Despite buyer interest in unique trim, add-ons, or appearance pieces, more often than not it is the aftermarket that fulfills these desires. Cost is the most quoted reason for the abyss between dream and reality at the OEM, but it is
Brain Cancer Risk and Electromagnetic Fields (EMFs): Assessing the Geomagnetic...
Archives of Environmental Health ALDRICH, TIM E. ANDREWS, KURTIS W. LIBOFF, ABRAHAM R. July 1, 2001 700+ words
RISK FACTORS for brain cancer are poorly understood, and few strong associations exist. Although brain cancer demonstrates the log-linear relationship...do not appear to be associated with brain cancer. Caucasians are about twice as likely...
Reportlinker Adds Chinese Markets for Brain Cancer Treatment Drugs.
Press release article from: PR Newswire November 3, 2009 700+ words
...its catalogue. Chinese Markets for Brain Cancer Treatment Drugs http://www.reportlinker...p0157400/Chinese-Markets-for-Brain-Cancer-Trea tment-Drugs.html#utm...campaign=prnewswire China's demand for Brain Cancer Treatment Drugs has grown at a fast...
Targeted therapies promise new hope for brain cancer patients.
Press release article from: M2 Presswire September 4, 2007 700+ words
...Targeted therapies promise new hope for brain cancer patients(C)1994-2007 M2 COMMUNICATIONS...many millions of dollars being invested into brain cancer research, primary brain cancer remains one of the most deadly diseases in...
Targeted therapies promise new hope for brain cancer patients; Datamonitor.
Newspaper article from: Pharma Marketletter October 1, 2007 700+ words
...many millions of dollars being invested into brain cancer research, primary brain cancer remains one of the most deadly diseases in...therapies may be able to improve survival of brain cancer patients. Deadly disease The most aggressive...
Genentech to Collaborate With Accelerate Brain Cancer Cure for Brain Cancer...
Press release article from: Business Wire February 25, 2002 700+ words
...Feb. 25, 2002--Accelerate Brain Cancer Cure (ABC(2)), a non-profit...specifically designed to treat patients with brain cancer. This collaboration represents the...improve the prospects for the treatment of brain cancer." "Brain cancer is not only an area...
CombinatoRx and ABC2 Initiate Brain Cancer Collaboration; Partnership Speeds...
Press release article from: PR Newswire September 27, 2004 700+ words
...pharmaceutical company, and Accelerate Brain Cancer Cure (ABC2), a non-profit foundation...accelerating therapies leading to a cure for brain cancer, today announced that they have initiated...target drugs for the treatment of brain cancer. The sponsored research will leverage...
Accelerate Brain Cancer Cure and National Brain Tumor Foundation Co-Fund Brain...
Press release article from: PR Newswire August 17, 2004 700+ words
...PRNewswire/ -- Accelerate Brain Cancer Cure (ABC2) and the National...diagnosed with this deadly form of brain cancer. ABC2 is dedicated to accelerating therapies leading to a cure for brain cancer and NBTF is dedicated to serving...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA